U.S. federal trademark · Serial No. 86690908 · Reg. No. 58199/2015
Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, [ autoinflammatory disease, autoimmune disease, ] blood disease, cancer, [ arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; ] pharmaceutical preparations, namely, cytokine inhibitory drugs; [ pharmaceutical preparations that modulate the immune system ]
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.